Summation Health Ventures returned for a series C round that lifted the healthcare communication system provider's total funding to $45m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

M2P-Labs, a supplier of microbioreactors based on RWTH Aachen intellectual property, has agreed to an acquisition by Beckman Coulter Life Sciences.

Telus Pollinator Fund for Good is equipped with $76.5m to invest in developers of technology that can promote positive social and environmental impact.

Baidu-backed Subtle Medical produces AI-driven medical imaging software intended to work across different healthcare systems, and has raised $12.2m.

Takeda Ventures and Astellas Venture Management both backed cell therapy developer Catamaran as it emerged from stealth.

George Washington and Minnesota universities-founded cell therapy developer Catamaran has raised cash to move two assets toward the clinic.

GV is among the investors in the pharmaceutical manufacturing technology startup, which recently secured $750m in series B funding.

The pharmaceutical firm will pay $425m up-front for University of Michigan and Ohio State University-founded OncoImmune after the latter pivoted its research pipeline to target severe cases of covid-19.

The Comcast and Anthem-backed telemedicine app developer closed its second round of the year, at a reported $700m valuation.